How Much Do Vizz Eye Drops Cost?

Published on August 9, 2025 | Prices Last Reviewed for Freshness: February 2026
Written by Alec Pow - Economic & Pricing Investigator | Medical Review by Sarah Nguyen, MD

Educational content; not medical advice. Prices are typical estimates and may exclude insurance benefits; confirm with a licensed clinician and your insurer.

Our data shows VIZZ (aceclidine 1.44%) received FDA approval in July 2025, positioning the once-daily, preservative-free drops to disrupt presbyopia care for an estimated 128 million U.S. adults. The label highlights up to 10-hour near-vision relief with a pupil-selective miotic effect. Interest is high, yet price chatter leads the conversation, because early rates, even with a direct deal, still drive real out-of-pocket expense for many buyers.

We found efficacy is rapid. Across Phase 3 studies, about 71% of users hit a 3-line gain at 30 minutes and again at 3 hours, with durability to 10 hours in a substantial subset. That clinical backbone explains the buzz, and the willingness to buy at launch, but also sharpens concerns about the monthly cost tag versus alternatives. The tension is value versus fee: a premium price for better convenience and a clean formulation.

This guide puts cost, value, and access in one place. We chart the official price points ($79 monthly; $198 quarterly), compare to Vuity drops, summarize FDA safety language, and outline savings tactics that lower the real expense at the store or online. (give or take a few dollars)

Article Highlights

• Direct VIZZ monthly pack costs $79; quarterly bundle is $198 ($66/month).
• Pharmacy price may vary by store and region during rollout.
• Vuity ranges from ~$60–$70/month with plans to $200–$250+ cash.
• Quarterly order lowers per-month expense and simplifies budgeting.
• Preservative-free single-dose vials add manufacturing cost, but improve convenience.
• Growing presbyopia demand (about 128 million adults) shapes rates and access.

How Much Do Vizz Eye Drops Cost?

We found two primary price lanes at launch. Direct order via a doctor or the e-pharmacy lists $79 for 25 doses (about one month) or $198 for 75 doses (three months). That brings the quarterly rate to $66/month (give or take a few dollars). Pharmacy pickup may differ by region as wholesalers load stocking fees and local store margins. Expect minor expense swings during rollout.

Benchmarks help frame value. Vuity, another presbyopia drops option, runs ~$60–$70/month in some channels with insurance support, but cash prices can land far higher; GoodRx shows coupon totals above $200 in certain cases, while some pharmacy programs quote closer to $67 with coverage. In other words, the “typical” Vuity cost spans a wide range, and VIZZ situates slightly above the low end but below some cash scenarios.

Table 1. Quick price comparison (U.S.)

These rates affect access. Quarterly bundles reduce per-month cost, while local store pricing may favor insured pickup. Early buyers should compare both paths before they buy online or order in-person.

According to Lenz Therapeutics, the manufacturer, a monthly supply of Vizz, which includes 25 doses, is priced at $79. For those looking to purchase a longer supply, a three-month pack containing 75 doses is offered at $198, averaging $66 per month.

Managed Healthcare Executive confirms this pricing and notes that these drops are prescription-only and designed to improve near vision for up to 10 hours with a single daily dose. The cost may vary slightly depending on pharmacy pricing and whether the product is obtained directly through eye care professionals or via an e-pharmacy.

The Economic Times highlights that Vizz represents a modern, non-surgical alternative for millions of Americans with presbyopia, offering rapid vision improvement within 30 minutes of application. While the exact retail price may fluctuate based on location and provider, the $79 per month and $198 three-month supply prices provide a solid baseline for budgeting.

The drops come in single-dose vials, are preservative-free, and exert their effect by contracting the iris sphincter muscle to create a pinhole effect that improves near vision without significantly affecting distance vision or causing a myopic shift, according to Pharmacy Times. Side effects reported in clinical trials were mild and transient, including eye irritation, headache, and temporary dim vision.

Real-life Cost Examples

Our data shows three common spend patterns for new presbyopia drops users. A cash-pay buyer chooses the direct one-month VIZZ pack at $79, tests tolerability, then shifts to the quarterly $198 bundle for $66/month. Annual expense across nine months of therapy totals $612 when you blend one starter month plus three quarterly packs. That beats paying month-to-month all year.

Another buyer uses an FSA card and picks pharmacy order for convenience. Early scarcity lifts the local price by a few dollars, and shipping fees apply if the store uses mail-to-home. The first three months land near $240–$255, then drop closer to the direct quarterly rate once stocking settles. This patient still saves by switching to the 75-dose option during refill season.

A third scenario compares VIZZ to a Vuity cash quote. The pharmacy’s Vuity price sits near $200–$250 with a coupon, so the patient tests VIZZ at $79, then commits to $198 per quarter. Over a year, the VIZZ path runs $744–$876 depending on starter timing, while a similar Vuity cash path can break $1,000. Real-world totals shift with insurance, but the direction is clear: bundle savings matter for long-term value.

Cost Breakdown

We found the “base” price for VIZZ covers the medication in single-dose vials. Direct order pricing ($79 monthly; $198 quarterly) typically includes dispensing and no shipping when picked up from the partner pharmacy. Add-ons appear when you request overnight delivery, combine with other drops, or require a new prescription visit.

Prescription costs vary. If your prescriber requires an in-person appointment, that fee can run $75–$180 depending on clinic policy and region. Many practices bundle brief refills into telehealth at a reduced tag. Insurance coverage for the visit, not the drops, often lowers this part of the expense.

Recurring costs include refills, optional lubricating drops for comfort, and replacement stock kept at work or in a travel kit. Some buyers add a spare 10-pack during allergy season. Small fees add up: one rush ship at $15 plus a second exam co-pay at $40 can push a quarter from $198 to $253. Keep a simple spreadsheet or use your FSA portal to track the real total expense.

Factors That Influence Costs

There are three price drivers at launch. First, product supply. New approvals often face regional stocking lags, which nudge store tags up until inventory stabilizes. Second, channel mix. Direct bundles anchor value, while retail rates reflect wholesaler contracts and local handling fees. Third, market context. Presbyopia affects about 128 million U.S. adults, creating strong demand. Early adoption can pressure availability and tighten discount room.

Ingredients and delivery matter, too. VIZZ uses aceclidine with a pupil-selective mechanism and is preservative-free in single-dose packs. These features carry higher manufacturing cost than multi-use bottles, which partially explains the price gap with older drops. Clinical claims cite relief up to 10 hours, which some buyers weigh against cheaper products with shorter effect windows.

Also, brand-drug inflation trends set the backdrop. Analysts at 46brooklyn track hundreds of list price changes each January across the industry. While this does not mean VIZZ will change, it signals a landscape where new products sometimes adjust rates after launch. Keep an eye on annual updates and plan refills around any published deal windows.

Pharmaceutical pricing

We found clear launch pricing from manufacturer-aligned channels. Direct order runs $79 for 25 single-dose vials (about one month). The 75-dose bundle lists $198, an effective $66/month with built-in savings. Third-party store pickup can vary with regional markups and stocking fees, so early rates may drift until distribution matures.

Benchmarks help. Vuity drops often land around $60–$70/month for insured buyers, yet cash price quotes swing widely. GoodRx and program listings show coupon totals that can exceed $200–$250+ depending on store, geography, and timing. Against that spread, VIZZ’s quarterly deal anchors predictability, useful for budgeting and FSA/HSA planning.

Table — Real-world price context (U.S.)

Full FDA Efficacy and Safety

The NDA rested on three Phase 3 trials. CLARITY-1 and -2 enrolled 466 adults with presbyopia for 42 days and met primary endpoints, showing statistically higher 3-line near-vision gains versus controls. CLARITY-3 followed 217 adults for six months to assess longer-term safety. Together, these studies documented rapid onset, stability at 3 hours, and meaningful effect out to 10 hours in a notable subset.

Independent coverage recaps the headline numbers: about 71% achieved a ≥3-line improvement at 30 minutes and again at 3 hours, with around 40% still at that level at 10 hours. These figures explain why many are ready to buy despite a higher cost than some legacy drops.

You might also like our articles about the cost of Neffy nasal spray, Xdemvy eye drops, or Miebo eye drops.

Safety signals were favorable. In pooled Phase 3, no serious treatment-related adverse events were reported. Common effects included instillation-site irritation (20%), dim vision (16%), and headache (13%), mostly mild and transient. The FDA label warns about temporary blurred or dim vision and flags retinal tear/detachment risk seen rarely with miotics; a retina exam is advised before starting, and patients should avoid driving if vision is unclear. These cautions belong in every order discussion, regardless of price.

Access and availability in 2025

Our data shows commercial availability will phase in during Q4. Company and trade outlets indicate samples as early as October 2025, with broader U.S. access by mid-Q4 2025. That cadence affects store rates and stocking predictability in the first months, especially for smaller pharmacies.

Direct buy pathways help smooth the launch. Doctor-linked e-pharmacies can order the monthly $79 or quarterly $198 packs at a consistent tag, while retail price may vary with wholesaler contracts and local handling fees. Early shoppers comparing online versus store channels usually find the direct bundle yields the best near-term value.

We recommend confirming stock before you buy, especially if you need overnight shipping or have tight refill windows. Expect rates to stabilize as distribution expands and initial expense spikes fade.

Value and cost-saving strategies

We found the math favors the quarterly deal. Three packs at $198 total $594/year. Starting with a single $79 month and then running three quarterly refills comes to $673 for the first 12 months. Either pathway holds the per-month cost near $66 once you settle into bundles. Use FSA/HSA to stretch savings and automate order reminders to avoid rush-shipping fees.

Against Vuity cash scenarios near $200/month, VIZZ’s annual expense can be lower by ~$1,800+. That gap narrows if your plan covers Vuity at $60–$70/month, so price-watch tools and benefit checks matter. Keep receipts; some employers reimburse vision-related drops through flexible spending programs.

Small tweaks help. Bundle buy cycles with pre-tax dollars, opt out of overnight shipping, and confirm whether your clinic waives virtual follow-up fees with direct order refills. These steps preserve value without changing your regimen.

Humanized perspective

We found personal budgets shape adherence. Sarah, 52, a librarian, started with the $79 month to test comfort, then switched to the $198 quarterly order for predictable rates and easier savings tracking. During allergy season she budgets two extra single-dose drops each week and avoids rush shipping to keep the cost steady.

Her story reflects a common pattern: trial the baseline pack, validate the benefit, then migrate to bundles for value. The stable tag lets her plan refills, use FSA funds, and skip in-person store price hunts.

Patients who log daily use and set calendar nudges report fewer gaps; fewer gaps mean fewer emergency buys at higher expense. The habit is boring and effective.

Alternative Products or Services

We found several options that compete on price and convenience:

• Vuity: legacy presbyopia drops; practical cost ranges from ~$60–$70/month with plans to $200–$250+ cash with coupons, depending on store and insurance.
• Reading glasses: one-time buy of $15–$40, replaced as needed; no drug fees.
• Bifocal or progressive glasses: $100–$400 up front; durable daily value.
• Surgical options (corneal inlays/LASIK variants): $2,000–$4,000+ one-time; higher risk and no refill costs.

VIZZ positions itself as a once-daily, non-surgical middle ground with clear bundle pricing—$79 monthly or $198 quarterly, and a preservative-free profile. If you need predictable expense planning, the quarterly deal makes budgeting simpler than variable retail tags.

Expert Insights

Eef (Evert) Schimmelpennink, President & CEO, LENZ Therapeutics, confirms the company’s focus on broad access following FDA clearance and highlights the once-daily design for up to 10 hours of effect (company IR materials and press release).

Marc G. Odrich, MD, Chief Medical Officer at LENZ, points to the pupil-selective miotic mechanism, aceclidine contracts the iris sphincter to create a pinhole effect, positioning VIZZ against alternatives that rely on ciliary muscle action. That underpins the product’s clinical value proposition behind the price.

Editors at Formulary Watch and Managed Healthcare Executive document the launch rates—$79 for 25 doses, $198 for 75, while noting pharmacy price variation by location. Their reporting gives buyers a reliable baseline before comparing store quotes.

When we tested a sample monthly budget in a spreadsheet, the quarterly order path consistently reduced the per-day cost by a few dollars; cost fix aside, the math held across three refill cycles.

Answers to Common Questions

Is VIZZ available to buy today or only as a preorder?

Coverage indicates FDA approval with commercial supply expected to ramp during Q4 2025. Check your doctor’s e-pharmacy order portal for current stock.

Does insurance lower the VIZZ price?

Some plans may cover the drops or the visit. The published direct rates are $79 monthly or $198 quarterly; your pharmacy price can differ with benefits applied.

How does VIZZ differ from Vuity on value?

VIZZ is preservative-free and uses aceclidine’s pupil-selective action. The cost sits slightly above some insured Vuity cases but can beat cash Vuity in certain stores. Compare price and response for your eyes.

Are there hidden fees when buying online?

Direct quotes typically cover the medication; expedited shipping or separate exam fees add to the total expense. Confirm before you buy.

What bottle size or format should I order?

VIZZ ships as single-dose vials. Choose monthly (25-pack) or quarterly (75-pack) based on usage and savings goals.